Mechanistic study of Small-molecular Therapy in diabetic Wound Healing

小分子治疗糖尿病伤口愈合的机制研究

基本信息

  • 批准号:
    10366031
  • 负责人:
  • 金额:
    $ 37.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Diabetic foot ulcers that lead to amputations are a major health problem affecting ~20% of the 30 million diabetic patients in the US. The current regimen has limited success, and the amputation rates remain high. Therefore, understanding molecular mechanisms for compounds with translational potential is a crucial step toward making a breakthrough in wound care protocols. Endothelial cells (ECs) are indispensable cellular components for wound angiogenesis. However, EC functions are impaired in patients with diabetes. The coformulation of two dietary compounds - Trans-resveratrol (tRES) and hesperetin (HESP) - improves glucose metabolic profile and arterial function in overweight and obese subjects through inducing the gene expression of glyoxalase 1 (GLO1), an enzyme that detoxifies reactive metabolites during glycolysis and protects cells against glycation stress. Our pilot data indicated that tRES+HESP improved wound healing in diabetic animals with an increase in GLO1 expression. However, its effects are likely far beyond inducing GLO1 expression because tRES+HESP treated ECs produced many pro-angiogenic factors, including angiopoietin-1 (ANGPT1) that plays an essential role in angiogenesis. Therefore, it is critical to determine proteins that are regulated by tRES+HESP in angiogenesis and tissue repair. The objective of this project is to fill the knowledge gap of the role of tRES+HESP in rescuing the disrupted angiogenesis in diabetes, and our long-term goal is to develop therapeutic strategies for diabetic wound repair. We hypothesize that tRES+HESP augments angiogenesis and improves diabetic wound healing through enhancing the expression of GLO1 and a potent pro-angiogenic factor, ANGPT1, and through novel changes in additional proteins in pathways critical to diabetic wound repair. Aim 1: Identification of molecular pathways and protein changes induced by tRES+HESP in human dermal microvascular ECs in vitro. Sub-aim 1: Determine to what extent tRES+HESP can rescue diabetic endothelial cell function in vitro. Sub-aim 2: Determine how vital ANGPT1 is in tRES+HESP-induced angiogenesis in vitro. Sub-aim 3: Discover new proteins and pathways responsible for the benefit of tRES+HESP treatment in endothelial cell function in vitro using state- of-the-art proteomics. Aim 2: Determine the therapeutic potential of tRES+HESP and its underlying molecular mechanisms in chronic diabetic wounds in vivo. Sub-aim 1: Determine the efficacy of tRES+HESP on wound healing in a newly developed diabetic chronic wound model in db/db mice. Sub-aim 2: Determine the role of ANGPT1 in the tRES+HESP-induced improvement in wound healing in vivo. Sub-aim 3: Discover new proteins and pathways responsible for the benefit of tRES+HESP treatment in diabetic wound repair in vivo using state- of-the-art proteomics. The outcome of the proposed research will determine the efficacy of topical application of this formula, tRES+HESP, in diabetic wound healing, and will unveil underlying molecular mechanisms for its beneficial effect. Since tRES+HESP has not been approved by the FDA to treat diabetic wound healing yet, these results may facilitate the FDA approval of this coformulation in diabetic wound treatment.
导致截肢的糖尿病足溃疡是一个主要的健康问题,影响到3000万糖尿病患者中的20%。 美国的病人。目前的治疗方案成功有限,截肢率仍然很高。因此,我们认为, 理解具有翻译潜力的化合物的分子机制是使 伤口护理协议的突破内皮细胞(EC)是不可或缺的细胞成分, 伤口血管生成然而,糖尿病患者的EC功能受损。两个人的共同表述 膳食化合物-反式白藜芦醇(tRES)和橙皮素(HESP)-改善葡萄糖代谢谱, 通过诱导谷胱甘肽酶1(GLO 1)的基因表达来改善超重和肥胖受试者的动脉功能, 一种在糖酵解过程中解毒反应性代谢物并保护细胞免受糖基化压力的酶。我们 初步数据表明,tRES+HESP改善了糖尿病动物的伤口愈合, 表情然而,它的作用可能远远超过诱导GLO 1表达,因为tRES+HESP处理的细胞中, 内皮细胞产生许多促血管生成因子,包括血管生成素-1(ANGPT 1),其在血管生成中起重要作用。 血管生成因此,确定在血管生成中由tRES+HESP调节的蛋白质是至关重要的 和组织修复。本项目的目标是填补tRES+HESP在救援中作用的知识空白 我们的长期目标是开发糖尿病的治疗策略, 伤口修复我们假设tRES+HESP增强血管生成并改善糖尿病伤口愈合 通过增强GLO 1和一种有效的促血管生成因子ANGPT 1的表达, 糖尿病伤口修复关键途径中其他蛋白质的变化。目的1:分子鉴定 tRES+HESP诱导的体外人真皮微血管内皮细胞中蛋白质的变化。次级目标 1:确定tRES+HESP在体外可以拯救糖尿病内皮细胞功能的程度。次级目标2: 确定ANGPT 1在tRES+ HESP诱导的体外血管生成中的重要性。子目标3:发现新蛋白质 和负责tRES+HESP治疗在体外内皮细胞功能中的益处的途径, 最先进的蛋白质组学目的2:确定tRES+HESP的治疗潜力及其基础分子 在体内慢性糖尿病伤口中的机制。子目标1:确定tRES+HESP对伤口的疗效 在db/db小鼠中新开发的糖尿病慢性伤口模型中的愈合。次级目标2:确定 ANGPT 1在tRES+ HESP诱导的体内伤口愈合改善中的作用。子目标3:发现新蛋白质 和负责tRES+HESP治疗在体内糖尿病伤口修复中的益处的途径, 最先进的蛋白质组学拟议研究的结果将决定局部应用的疗效 该公式,tRES+HESP,在糖尿病伤口愈合,并将揭示其潜在的分子机制, 有益效果。由于tRES+HESP尚未被FDA批准用于治疗糖尿病伤口愈合, 这些结果可促进FDA批准该共制剂用于糖尿病伤口治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiemei Wang其他文献

Jiemei Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiemei Wang', 18)}}的其他基金

Mechanistic study of Small-molecular Therapy in diabetic Wound Healing
小分子治疗糖尿病伤口愈合的机制研究
  • 批准号:
    10569598
  • 财政年份:
    2021
  • 资助金额:
    $ 37.47万
  • 项目类别:
Role of Inositol requiring enzyme 1 in regulating angiogenesis for diabetic wound repair.
需要酶 1 的肌醇在调节糖尿病伤口修复血管生成中的作用。
  • 批准号:
    9222758
  • 财政年份:
    2016
  • 资助金额:
    $ 37.47万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了